1-20 of 25806
Save search
Sort by
Journal Article
ACCEPTED MANUSCRIPT

Histology in IBD: A Redundant Tool or a Valuable Prognostic Marker? Get access

PDF
Matthias Lenfant and others
Journal of Crohn's and Colitis, jjaf064, https://doi.org/10.1093/ecco-jcc/jjaf064
Published: 18 April 2025
Journal Article
ACCEPTED MANUSCRIPT

Biglycan deficiency alleviates intestinal fibrosis through BMP-7-mediated Smad1/5/8 signaling Get access

PDF
Mengli Yu and others
Journal of Crohn's and Colitis, jjaf065, https://doi.org/10.1093/ecco-jcc/jjaf065
Published: 18 April 2025
Journal Article
ACCEPTED MANUSCRIPT

Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Crohn’s Disease and Ulcerative Colitis: 2-Year Results from Open-Label Extensions of Two Randomized Controlled Trials (LIBERTY) Get access

PDF
Jean-Frederic Colombel and others
Journal of Crohn's and Colitis, jjaf060, https://doi.org/10.1093/ecco-jcc/jjaf060
Published: 17 April 2025
Image
Graphical abstract

Graphical abstract Get access

Published: 17 April 2025
Graphical Abstract Graphical abstract
Journal Article
ACCEPTED MANUSCRIPT

Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitis Get access

PDF
Bram Verstockt and others
Journal of Crohn's and Colitis, jjaf063, https://doi.org/10.1093/ecco-jcc/jjaf063
Published: 17 April 2025
Image
Graphical abstract

Graphical abstract Get access

Published: 10 April 2025
Graphical Abstract Graphical abstract
Journal Article
ACCEPTED MANUSCRIPT

Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study of GETECCU Get access

PDF
Esteban Fuentes-Valenzuela and others
Journal of Crohn's and Colitis, jjaf058, https://doi.org/10.1093/ecco-jcc/jjaf058
Published: 10 April 2025
Image
Graphical Abstract

Graphical Abstract Get access

Published: 09 April 2025
Graphical Abstract Graphical Abstract
Journal Article
ACCEPTED MANUSCRIPT

Association of Bile Acid Diarrhea with Symptoms and Disease Activity in Crohn’s Disease: Post-Hoc Clinical Trial Analysis of Serum 7a-hydroxy-4cholestern-3-one, C4, in Patients with Active Crohn’s Disease Get access

PDF
Robert Battat and others
Journal of Crohn's and Colitis, jjaf053, https://doi.org/10.1093/ecco-jcc/jjaf053
Published: 09 April 2025
Image
Graphical abstract

Graphical abstract

Published: 01 April 2025
Graphical Abstract Graphical abstract
Image
Graphical abstract

Graphical abstract Get access

Published: 01 April 2025
Graphical Abstract Graphical abstract
Image
Graphical Abstract

Graphical Abstract

Published: 01 April 2025
Graphical Abstract Graphical Abstract
Image
Clinical and endoscopic endpoints by corticosteroid use at week 12 of induc...

Clinical and endoscopic endpoints by corticosteroid use at week 12 of induc...

Published: 01 April 2025
Figure 1. Clinical and endoscopic endpoints by corticosteroid use at week 12 of induction. Shown are the percent of patients who achieved clinical remission (A), clinical response (B), endoscopic improvement (C), endoscopic remission (D), and HEMI (E) by baseline corticosteroid use at week 12 of induction. R
Journal Article
ACCEPTED MANUSCRIPT

Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicentre retrospective cohort study

PDF
Daniele Noviello and others
Journal of Crohn's and Colitis, jjaf056, https://doi.org/10.1093/ecco-jcc/jjaf056
Published: 01 April 2025
Journal Article

Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis

PDF
Walter Reinisch and others
Journal of Crohn's and Colitis, Volume 19, Issue 4, April 2025, jjaf025, https://doi.org/10.1093/ecco-jcc/jjaf025
Published: 01 April 2025
Journal Article
ACCEPTED MANUSCRIPT

Patient–donor similarity and donor-derived species contribute to the outcome of faecal microbiota transplantation for ulcerative colitis Get access

PDF
Dai Ishikawa and others
Journal of Crohn's and Colitis, jjaf054, https://doi.org/10.1093/ecco-jcc/jjaf054
Published: 01 April 2025
Image
Discontinuation of corticosteroid use in patients taking corticosteroids at...

Discontinuation of corticosteroid use in patients taking corticosteroids at...

Published: 01 April 2025
Figure 2. Discontinuation of corticosteroid use in patients taking corticosteroids at baseline of the induction study through week 52 of maintenance. The mandatory CS taper was initiated at maintenance week 0 and completed by week 8. Shown are the percentage of patients who had discontinued CS use (complete
Journal Article
ACCEPTED MANUSCRIPT

The mediating role of psychological inflexibility on internalised stigma and patient outcomes in a sample of adults with inflammatory bowel disease

PDF
Darren P Reynolds and others
Journal of Crohn's and Colitis, jjaf055, https://doi.org/10.1093/ecco-jcc/jjaf055
Published: 01 April 2025
Image
Corticosteroid-free clinical and endoscopic outcomes in the overall populat...

Corticosteroid-free clinical and endoscopic outcomes in the overall populat...

Published: 01 April 2025
Figure 3. Corticosteroid-free clinical and endoscopic outcomes in the overall population and by advanced therapy status at week 52 of maintenance. Shown are the percent of patients who achieved corticosteroid-free clinical remission (A), corticosteroid-free endoscopic improvement (B), corticosteroid-free end
Journal Article
ACCEPTED MANUSCRIPT

Real-world Effectiveness of Ustekinumab Versus Anti-TNF or Vedolizumab in Ulcerative Colitis: Induction and 12-Month Maintenance Results from the Prospective, Observational RUN-UC Study Get access

PDF
Bernd Bokemeyer and others
Journal of Crohn's and Colitis, jjaf052, https://doi.org/10.1093/ecco-jcc/jjaf052
Published: 27 March 2025